Find information on how we’re keeping you safe from COVID-19 here
Areas of Expertise
Mr Kinross performs a range of treatments, including:
- Trans Anal Minimally Invasive Surgery (TAMIS) for early rectal cancer and complex polyps
- Robotic surgery
- Transanal Haemorrhoidal Dearterialisation (THD), banding and haemorrhoidectomy
- Laparoscopic surgery
- Abdominal resection
- Colorectal surgery
- Bowel diversion surgery
- Removal of rectum and colon
- Transanal endoscopic microsurgery
Some of the conditions he commonly treats are:
- Gut microbiome
- Irritable bowel syndrome, constipation and chronic diarrhoea
- Anal cancer
- Crohn’s disease
- Inflammatory bowel disease
- Rectal cancer
- Femoral hernia
- Inguinal hernia
- Anal fistula
- Colon cancer
- Faecal incontinence
- Pelvic floor dysfunction
- Bowel obstruction
Dr James Kinross FRCS PhD is a Consultant Colorectal Surgeon at St. Mary’s Hospital London. He was trained in northwest London, and was a National Institute for Health Research clinical lecturer in surgery, and an Ethicon laparoscopic fellow in colorectal surgery.
He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer.
He is a visiting professor at the Royal College of Surgeons of Ireland and is currently funded by Bowel and Cancer Research and the NIHR Imperial Biomedical Research Centre.
Mr Kinross has published over 60 peer-reviewed papers and authored countless book chapters, whilst also presenting at over 30 international conferences.
Research and Awards
Mr Kinross’ current research interests include:
- The gut microbiome and colorectal cancer
- Intelligent surgical devices- iKnife
- Computational biology
- Surgical nutrition
- Surgical robotics
- Augmented reality
- Machine learning and digital surgery
He performs clinical trials using intra-operative mass spectrometry (known as the iKnife) for improving the precision of the surgical treatment of colorectal cancer. He also studies the role of the gut microbiome in the aetiology of colon cancer, Crohn’s disease and obesity.
He is performing clinical research at Imperial College London and at the Royal Marsden Hospital. The aim is to develop novel biomarkers for the early detection of bowel cancer, and to develop novel therapies for its treatment based on a deeper understanding of how the microbiota that reside in the gut influence tumour biology and the response of cancer to treatment.
Finally, he has a separate interest in the educational application of virtual worlds and gaming technologies for surgical and medical education. He works as part of a team that is building next generation, immersive simulators for use in major incidents and trauma training.
Getting to Know Mr James Kinross
Mr Kinross enjoys cycling as he finds endurance exercise good for clearing the head.